Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-13-001950
Filing Date
2013-02-28
Accepted
2013-02-28 16:28:22
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2213226z10-k.htm 10-K 1213326
2 EX-21 a2213226zex-21.htm EX-21 3417
3 EX-23.1 a2213226zex-23_1.htm EX-23.1 3242
4 EX-31.1 a2213226zex-31_1.htm EX-31.1 7670
5 EX-31.2 a2213226zex-31_2.htm EX-31.2 7883
6 EX-32.1 a2213226zex-32_1.htm EX-32.1 4846
13 G827874.JPG g827874.jpg GRAPHIC 55109
14 G600803.JPG g600803.jpg GRAPHIC 42190
  Complete submission text file 0001047469-13-001950.txt   8990869

Data Files

Seq Description Document Type Size
7 EX-101.INS mnta-20121231.xml EX-101.INS 1074298
8 EX-101.SCH mnta-20121231.xsd EX-101.SCH 84324
9 EX-101.CAL mnta-20121231_cal.xml EX-101.CAL 89131
10 EX-101.LAB mnta-20121231_lab.xml EX-101.LAB 1289484
11 EX-101.PRE mnta-20121231_pre.xml EX-101.PRE 548827
12 EX-101.DEF mnta-20121231_def.xml EX-101.DEF 321702
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

EIN.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50797 | Film No.: 13652516
SIC: 2836 Biological Products, (No Diagnostic Substances)